Cancer clinical trials in the region Auvergne-Rhône-Alpes
487 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Colon cancer
Rectal cancer
Stomach and esophageal cancer
#NCT06245356
#2023-508724-35-00
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Metastatic
None
Systemic Treatment-Naive
4 recruiting sites
UNICANCER
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04678362
#2024-516182-37-01
Invasive bladder cancer
Upper excretory tract cancer
Urethral cancer
Urothelial carcinoma
Other
Locally Advanced
Metastatic
None
Chemotherapy
Immunotherapy
Targeted therapy
10 recruiting sites
Centre François Baclesse
Phase 2
Sarcoma and GIST
#NCT04698785
Bone sarcoma
Locally Advanced
None
1
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
9 recruiting sites
Centre Léon Bérard
Phase 2
Acute leukemia
#NCT05260528
#2022-500295-60-00
Acute myeloid leukemia (AML)
None
31 recruiting sites
Centre Hospitalier Universitaire de Nice
Phase 2
Sarcoma and GIST
#NCT04874311
#2020-005703-39
Soft tissue sarcoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Chemotherapy
3 recruiting sites
Institut Bergonié
Phase 2
Pancreas cancer
Sarcoma and GIST
#NCT05732831
#2022-502645-99-00
Bone sarcoma
Soft tissue sarcoma
Adenocarcinoma
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Tango Therapeutics
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT05489211
#2022-000776-19
Cancer urothélial (sous-étude 6)
Invasive bladder cancer
Urothelial carcinoma
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
2 recruiting sites
AstraZeneca
Phase 2
Prostate cancer
#NCT06172478
#2023-507641-29-00
Cancer de la prostate résistant à la castration
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
9 recruiting sites
Daiichi Sankyo
Phase 2
Lung cancer
#NCT06172478
#2023-507641-29-00
Cancer du poumon
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
1
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
9 recruiting sites
Daiichi Sankyo
Phase 2
Head and neck cancer
#NCT06172478
#2023-507641-29-00
Carcinomes épidermoïdes de la tête et du cou
Oral cavity
Oropharynx
Hypopharynx
Larynx
Locally Advanced
Metastatic
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
9 recruiting sites
Daiichi Sankyo